Is MGM-15 (dihydro-7-hydroxymitragynine) Legal in Iowa? (2026)

Is MGM-15 Legal? Every state and federal law

Iowa MGM-15 ban status: ban in force

Federal

Federal Schedule I (DEA temporary order, drug code 9673), effective 2026-08-26 to 2028-08-26 (effective 2026-08-26). State-law reading underneath: Gray area.

Rule type

permanent

Tier

Under review

What the record says

Iowa Code 124.201(4) provides that when a new substance is designated as controlled under federal law and notice is given to the board, the board shall similarly designate it after thirty days from Federal Register publication of a final order, unless the board objects, and treats that designation as a temporary amendment to the schedules. The text speaks of a final order and of a board designation, and Iowa practice implements federal temporary scheduling through Board of Pharmacy rulemaking under 481 IAC 553.13; reach of the DEA temporary order into Iowa law therefore depends on board action and on reading a temporary order as within the subsection, so the row is restricted and interpretive rather than illegal. As of retrieval, 481 IAC 553.13 (IAC 9/30/26) does not list MGM-15; a Notice of Intended Action (Regulatory Analysis RA 26-323, IAB 9/30/2026, hearing 2026-10-20) proposes adding MGM-15 (dihydro-7-hydroxymitragynine) to Iowa Code 124.204(9) in response to the federal action, which is a pending rule and does not set status. Checked and absent: no named listing in Iowa Code 124.204 or any 2026 Iowa Act; Iowa does not schedule 7-OH, mitragynine or kratom (HF 2133 and SF 2192 of 2026 did not pass the Senate), so there is no 7-OH derivative language; no kratom consumer protection act; no whole-plant ban; no general controlled-substance-analog offense in chapter 124. The general definition of opiate in Iowa Code 124.101 (addiction-forming liability similar to morphine) is an untested catch-all theory and is not relied on. Federally, the compound is Schedule I under the DEA temporary scheduling order (DEA-1644, FR Doc. 2026-17429, effective 2026-08-26 to 2028-08-26); that federal control applies regardless of this state row.

Controlling language, verbatim

4. If any new substance is designated as a controlled substance under federal law and notice of the designation is given to the board, the board shall similarly designate as controlled the new substance under this chapter after the expiration of thirty days from publication in the federal register of a final order designating a new substance as a controlled substance, unless within that thirty-day period the board objects to the new designation.

Source of excerpt

Citations

1. Iowa Code 124.201(4) (Iowa Legislature, 2026-10-28) PRIMARYOFFICIAL
2. Iowa Code 124.204 (Schedule I) (Iowa Legislature, 2026-10-28)OFFICIAL
3. 481 IAC 553.13 Temporary designation of controlled and precursor substances (Iowa Legislature (Iowa Administrative Code), 2026-10-28)OFFICIAL
4. Regulatory Analysis RA 26-323, Notice of Intended Action, 481 IAC 553.13 (IAB 9/30/2026) (Iowa Board of Pharmacy / Iowa Administrative Bulletin, 2026-10-28)OFFICIAL

Where MGM-15 (dihydro-7-hydroxymitragynine) stands across the country

Among Iowa’s 6 neighbors, Illinois, Minnesota, Missouri, Nebraska, South Dakota and Wisconsin are illegal, the same posture as Iowa.

Open the interactive map · Every compound in Iowa · Where MGM-15 is banned · Embed this map

Federal posture

Federally scheduled or prohibited. Federal Schedule I (DEA temporary order, drug code 9673), effective 2026-08-26 to 2028-08-26 Federal detail

Verbatim law on file for Iowa

1 instrument on file for this compound’s framework in Iowa; 4 of 4 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

1. The board shall administer the regulatory provisions of this chapter. Annually, within
thirty days after the convening of each regular session of the general assembly, the board
shall recommend to the general assembly any deletions from, or revisions in the schedules
of substances, enumerated in section 124.204, 124.206, 124.208, 124.210, or 124.212, which
it deems necessary or advisable.
In making a recommendation to the general assembly
regarding a substance, the board shall consider the following:

a. The actual or relative potential for abuse;
b. The scientific evidence of its pharmacological effect, if known;
c. State of current scientific knowledge regarding the substance;
d. The history and current pattern of abuse;
e. The scope, duration, and significance of abuse;
f. The risk to the public health;
g. The potential of the substance to produce psychic or physiological dependence liability;

and

h. Whether the substance is an immediate precursor of a substance already controlled

under this subchapter.

2. After considering the factors described in subsection 1, the board shall make a
recommendation to the general assembly, specifying the change which should be made in
existing schedules, if it finds that the potential for abuse or lack thereof of the substance is
not properly reflected by the existing schedules.

3.

If the board designates a substance as an immediate precursor, substances which are
precursors of the controlled precursor shall not be subject to control solely because they
are precursors of the controlled precursor. Such designations shall be made pursuant to the
procedures of chapter 17A.

4.

If any new substance is designated as a controlled substance under federal law and
notice of the designation is given to the board, the board shall similarly designate as controlled
the new substance under this chapter after the expiration of thirty days from publication in
the federal register of a final order designating a new substance as a controlled substance,
unless within that thirty-day period the board objects to the new designation. In that case the
board shall publish the reasons for objection and afford all interested parties an opportunity
to be heard. At the conclusion of the hearing the board shall announce its decision. Upon
publication of objection to a new substance being designated as a controlled substance under
this chapter by the board, control under this chapter is stayed until the board publishes its
decision. If a substance is designated as controlled by the board under this subsection the
control shall be considered a temporary amendment to the schedules of controlled substances
in this chapter. If the board so designates a substance as controlled, which is considered
a temporary amendment to the schedules of controlled substances in this chapter, and if
the general assembly does not amend this chapter to enact the temporary amendment and
make the enactment effective within two years from the date the temporary amendment
first became effective, the temporary amendment is repealed by operation of law two years
from the effective date of the temporary amendment. A temporary amendment repealed by
operation of law is subject to section 4.13 relating to the construction of statutes and the
application of a general savings provision.

Related

MGM-15 (dihydro-7-hydroxymitragynine) in neighboring states

• MGM-15 (dihydro-7-hydroxymitragynine) in Illinois Illegal
• MGM-15 (dihydro-7-hydroxymitragynine) in Minnesota Illegal
• MGM-15 (dihydro-7-hydroxymitragynine) in Missouri Illegal
• MGM-15 (dihydro-7-hydroxymitragynine) in Nebraska Illegal
• MGM-15 (dihydro-7-hydroxymitragynine) in South Dakota Illegal
• MGM-15 (dihydro-7-hydroxymitragynine) in Wisconsin Illegal

Closest to MGM-15 in Iowa

• 7-OH (7-Hydroxymitragynine) in Iowa Legal
• Kratom (Whole Leaf / Mitragynine) in Iowa Legal
• Mitragynine Pseudoindoxyl in Iowa Illegal
• MGM-16 (9-fluoro-dihydro-7-hydroxymitragynine) in Iowa Illegal
• 9-OH (9-hydroxycorynantheidine) in Iowa Legal
• Speciociliatine in Iowa Legal

Cite this page